Diphex

Quick links to important sections

Diphex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diphex

Quick Facts

Property Description
Active Ingredients Ammonium Chloride, Chlorobutanol, Diphenhydramine, Sodium Citrate
Form Oral solution (syrup)
Pharmacological Class Antihistaminic-Expectorant-Antitussive combination
Common Use Integrated symptomatic relief for cough and cold discomfort
Origin Synthetic compound

What is Diphex? Definition and Pharmacological Classification

Diphex is a synthetic, fixed-dose combination product categorized as a multi-ingredient cough and cold preparation. This specific oral solution is classified within the Antihistaminic-Expectorant-Antitussive combination pharmacological class, a blend which is clinically recognized for its comprehensive approach to managing complex respiratory symptoms. As a combination product, Diphex is manufactured and positioned to simplify the concurrent management of multiple, interconnected symptoms in the patient population, which is a key differentiating factor from single-active ingredient remedies.

The Active Composition of the Diphex Oral Solution

The formulation's identity is defined by the synergistic presence of four distinct active ingredients: Diphenhydramine Hydrochloride, Ammonium Chloride, Chlorobutanol, and Sodium Citrate. Diphenhydramine is confirmed as a first-generation H1-receptor antagonist (antihistamine). The primary benefit of this component is to reduce allergic responses and irritation that often trigger a cough. The oral solution presentation of Diphex is notable for its inclusion of Chlorobutanol, which functions as a pharmaceutical preservative. This inclusion helps maintain the stability and integrity of the liquid preparation over time, ensuring product consistency. The ingredients also include Ammonium Chloride, an expectorant, and Sodium Citrate, a mucolytic, which work together to modify and thin respiratory secretions.

General Purpose: Integrated Symptomatic Relief

The general therapeutic purpose of Diphex is to achieve integrated symptomatic relief by mitigating multiple forms of respiratory and allergic discomfort simultaneously. This combination targets the primary pathways of distress, including the reflexive cough, the allergic irritation mediated by histamine, and the thickness of bronchial secretions. By incorporating both antitussive and secretion-modifying capabilities, the preparation supports the moderation of the cough reflex while facilitating the effective clearance of mucus, aiding in the management of complex respiratory discomfort and promoting patient well-being.

Regulatory References

  1. Diphenhydramine - DailyMed - NIH

What side effects are possible with Diphex?

Possible Side Effects and Safety Information

The official safety profile of this multi-ingredient oral solution, which contains the first-generation antihistamine Diphenhydramine, is classified by regulatory authorities into frequency and physiological system groupings. This profile is defined by Common central nervous system (CNS) and anticholinergic effects.

Adverse Reaction Classification

Category Documented Effects (Examples)
Common Sedation, sleepiness, dry mouth, dizziness, disturbed coordination.
Rare Hypotension, palpitations, convulsions, certain blood disorders (e.g., hemolytic anemia).

These effects primarily involve the Nervous System and Gastrointestinal System, with anticholinergic effects like dry mouth and urinary retention being recognized within the common range. Regulatory documentation notes that drowsiness and sedation usually diminish after a few days of exposure.

Key Safety Constraints

The regulatory profile explicitly documents Serious Adverse Reactions, including anaphylactic shock and certain blood disorders, classified as rare or of unknown incidence. Specific safety considerations apply to certain patient groups and underlying conditions:

  • Organ Impairment: Use is restricted for individuals with severe hepatic or renal function impairment.
  • Vulnerable Populations: Older adults are cited as being more susceptible to the common effects of dizziness and hypotension. Pediatric patients may exhibit paradoxical excitation. Use is generally not recommended for nursing mothers.
  • Pre-existing Conditions: Caution is required for patients with conditions such as narrow-angle glaucoma, stenosing peptic ulcer, or prostatic hypertrophy due to the anticholinergic properties of the active ingredients.

Combining the medicine with alcohol or other CNS depressants results in additive depressant effects, which is a high-level safety consequence defined in the official labeling.

Overdose and Emergency Response

Overdose and when to seek help

Overdose involving this combination product is defined by documented risks of acute neurological and cardiovascular toxicity, primarily from the Diphenhydramine component. Officially documented overdose presentations include severe central nervous system effects such as confusion, delirium, hallucinations, seizures, and coma. Other clinical manifestations are marked anticholinergic signs like dry mouth, blurred vision, enlarged pupils, and urinary retention. Exposure to large quantities of the Ammonium Chloride component can also lead to metabolic acidosis and subsequent neurological impairment.

The regulatory profile classifies this as a potentially life-threatening scenario due to the risk of serious heart problems, including QRS widening, arrhythmias, and cardiac arrest. Pediatric patients may exhibit initial paradoxical stimulation before the onset of CNS depression. Due to these documented severe outcomes, official regulatory statements mandate that individuals seek immediate medical attention and contact poison control services immediately for any suspected overdose. Immediate medical help is explicitly required if the person is hallucinating, cannot be awakened, has a seizure, has trouble breathing, or has collapsed. Management in a medical setting focuses on symptomatic and supportive treatment, including necessary cardiac monitoring via ECG/EKG and the use of pharmacological interventions like Sodium Bicarbonate for specific cardiotoxicity, as no specific antidote is known for the primary toxic components.

Therapeutic Uses of Diphex

What Diphex Treats: Main Uses and Benefits

The preparation is a multi-symptom therapy used in situations involving certain distressing symptoms of the common cold, flu, and allergic irritation. Combinations of antitussives, expectorants, and antihistamines may be considered relevant for addressing these varied manifestations.

Integrated Symptom Relief

This combination product is commonly used across conditions presenting with acute episodes of respiratory discomfort. It helps address symptom clusters that may become intense or disruptive, including a dry, irritating cough, a chesty cough with thick mucus, sneezing, and a runny nose. This application provides support that helps ease the overall symptom burden during difficult episodes, particularly those where temporary functional strain or discomfort is present. It is relevant in clinical settings marked by increased discomfort or tension, and its use may be part of symptomatic management for the common cold, flu, or seasonal allergic manifestations.

“The product is applied to provide supportive relief that helps patients cope more steadily with temporary symptom fluctuations.”

Quick Fact: Relief for Dual Cough and Congestion

Domain Focus
Cough Type Irritating, non-productive cough, and chesty, mucus-producing cough
Symptom Cluster Cough, phlegm/mucus buildup, nasal discharge, and sneezing
Primary Benefit Moderates cough reflex and supports maintaining comfort

Regulatory References

  1. NIH MedlinePlus overview on cold and cough medicines

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Diphex eligibility is strictly defined by government regulatory classifications, primarily due to the presence of the antihistamine component, Diphenhydramine.


Absolute Contraindications (Who Must Not Use)

The medicine is officially contraindicated for patients with a known hypersensitivity to Diphenhydramine or any formulation component. Use is strictly prohibited for individuals currently taking or having recently taken Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days. Diphex is also contraindicated in neonates, premature infants, and nursing mothers. Specific pre-existing conditions that are sensitive to anticholinergic action also preclude use, including narrow-angle glaucoma and conditions causing urinary retention, such as symptomatic prostatic hypertrophy.


Restricted and Conditional Use

Use is considered restricted and requires caution in several populations. This includes older adults (aged 60 and over) due to increased susceptibility to adverse effects. Patients with a history of bronchial asthma, cardiovascular disease, hypertension, hyperthyroidism, or those with hepatic or renal impairment are officially advised to use the medicine with care. Use during pregnancy is permitted only if clearly needed and if the potential benefit justifies the possible risk.

What should I know about interactions with other medicines?

Diphex Interactions with other medicines and products

Official regulatory documentation identifies two main classes of serious pharmacodynamic interactions for Diphex. Central Nervous System (CNS) Depressants, including alcohol, sedatives, hypnotics, tranquilizers, opioid pain relievers, and other muscle relaxants, carry a risk of additive effects, significantly increasing drowsiness and other depressant effects.


The most serious documented interaction is with Monoamine Oxidase Inhibitors (MAOIs), which are explicitly stated to prolong and intensify the anticholinergic (drying) effects of Diphex, potentially leading to serious, life-threatening side effects. The official regulatory instruction mandates a 14-day clearance period following the cessation of an MAOI before beginning therapy with Diphex, including specific MAOIs such as Isocarboxazid, Phenelzine, and Methylene Blue injection.


Additional official constraints include avoiding co-use with Ketoconazole and Levoketoconazole, and any other medicinal product containing an antihistamine. The medication may also interfere with the results of certain medical/lab tests, such as allergy skin testing.

Mechanism of Action

How Diphex Works: Mechanism of Action

Diphex functions through a three-pronged, localized physicochemical mechanism, directly targeting external chemical aggressors rather than internal biological receptors or pathways.

Immediate Chemical Neutralization

This domain covers the amphoteric action, which involves a direct, rapid reaction with corrosive agents (acids and bases) at the contact site. This interaction immediately arrests the chemical burning process and restores the localized tissue pH to the normal physiological range, thereby halting the destruction of cellular proteins and lipids.

Active Reverse Osmotic Extraction

This mechanism utilizes the solution's hypertonicity to create an osmotic gradient across the tissue. This gradient induces a reverse fluid flux, actively pulling penetrated chemical molecules out of the deeper tissue layers. This action limits the depth of penetration of the chemical, influencing the extent of tissue destruction and altering local nociceptive pathway activity.

Broad-Spectrum Inactivation

The final component is chelation, where Diphex binds and inactivates various reactive chemical species (such as metal ions and certain oxidizing agents) that are not solely neutralized by pH adjustment. This mechanism expands the overall mechanistic applicability, safeguarding structural integrity against a wider range of chemical species.

Dosage and Administration Information

How to Use Diphex: Official Administration Guidelines

Diphex, an oral solution combining an antihistamine, expectorant, and mucolytic, is administered strictly via the oral route for short-term, intermittent symptomatic use. The official prescribing information defines precise parameters for administration, dosage volume, and frequency to ensure proper use of the combination product.

Administration Scope

Feature Guideline
Route of administration Oral administration only.
Dosing schedule (Adults/Adolescents) The standard single dose is 5 mL to 10 mL. The required volume must be accurately measured using a calibrated device.
Dosing Frequency Doses are administered as-needed, with a minimum interval of every 4 hours between administrations.
Age-group administration rules The product is not suitable for children under 12 years of age, establishing a clear minimum age threshold for use.
Special procedural conditions The total volume administered must not exceed 4 doses in any 24-hour period.

Official Procedural Structure

Procedural Element Description
Preparation The solution is ready-to-use and does not require dilution or reconstitution.
Administration The measured volume is taken orally by swallowing.
Limitation Strict adherence to the 24-hour maximum of four total doses is required.

This protocol defines a standardized, volume-based dosing pattern that is conditional on time intervals, formally restricting the cumulative daily intake. This approach ensures the medicine is used according to the precise constraints outlined in regulatory documents.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diphex

Evidence for Use in Symptomatic Management of Acute Cough

The research base for Diphex, a combination product, primarily consists of studies examining short-term symptom patterns in conditions associated with acute cough. The evidence was evaluated in the context of short-term randomized trials and systematic reviews focused on the established antitussive and expectorant components, rather than numerous dedicated trials for the specific four-ingredient formulation.

Research examined how symptoms evolved in adult populations presenting with acute cough. Studies focused on outcomes related to physical discomfort, monitoring changes in cough frequency and intensity. Findings describe patterns observed in trials related to changes in cough measurements in comparison to an inert substance (placebo). However, findings were mixed regarding the consistent contribution of expectorant components within the context of non-productive cough. The studies were typically conducted over a short duration, reflecting the acute nature of the condition.

Evidence for Relief of Acute Respiratory and Allergic Symptoms

Diphex was evaluated in the context of integrated symptom relief for the common cold or seasonal allergic irritation. Research explored symptom clusters typical of conditions characterized by fluctuating or episodic manifestations. The evidence includes studies that focused heavily on the antihistamine component (Diphenhydramine) for patient-reported outcomes describing perceived discomfort associated with symptoms like sneezing and runny nose.

Studies observed patterns of temporary change in allergic and irritative symptoms in the observed adult and adolescent populations. The evidence contributes to the broader evidence landscape consistent with the combination's rationale for addressing multiple symptoms simultaneously.

What Is Still Uncertain About Diphex Research

The evidence landscape is marked by several research limitations. Comparative evidence is lacking for the specific four-ingredient fixed-dose combination when measured directly against other single-active cold medications. Furthermore, the evidence quality varies across studies, especially regarding the clinical importance of the expectorant/mucolytic ingredients. Sample sizes were modest in some targeted trials, and the results apply only to the populations studied. There is limited information for long-term outcomes, and certainty remains low in areas where data for long-term effects are not fully established.

Key Studies & References

  1. Efficacy of diphenhydramine against cough in humans: a review
  2. Cough (acute): antimicrobial prescribing - Summary of the evidence (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Diphex (FAQ)


Q: Is it safe to take Diphex with my blood pressure medicine?

According to the official product information, caution is advised for individuals who have pre-existing conditions such as cardiovascular disease or high blood pressure (hypertension). This is because the effects of the medicine may require special monitoring. Regulatory documents indicate that use of the medicine with certain health conditions or medications warrants professional guidance.


Q: Does Diphex affect my sleep or cause insomnia?

Official safety information states that common effects include sedation and sleepiness. However, studies have examined rare instances of paradoxical excitation, which is the opposite of sedation. This effect can be characterized by symptoms such as nervousness or insomnia and has been noted particularly in specific, vulnerable patient populations.


Q: What is the difference between a drug allergy and a common side effect of Diphex?

A common side effect, like dry mouth or drowsiness, is a known and predictable adverse reaction listed in the safety profile. In contrast, an allergy (or hypersensitivity) is an immune system response to an ingredient in the medicine. Official documents list known hypersensitivity as an absolute contraindication, meaning the medicine must not be used at all if an allergy is known.


Q: Do studies support the use of Diphex for all stages of my condition?

Evidence indicates that the research base is primarily focused on the short-term symptomatic use of the active ingredients. Regulatory summaries have noted that the evidence is limited regarding long-term use and outcomes. This suggests that the evidence base is stronger when the medicine is used for the acute, or short-term, management of symptoms.


Q: Is a headache or nausea a normal side effect when starting Diphex?

Official safety documentation notes that the medicine affects the Gastrointestinal System. While common side effects include dry mouth and disturbed coordination, the official profile typically includes other documented gastrointestinal effects, such as nausea or vomiting, that have been reported by patients.


Q: Are there any vitamins or supplements that interact with Diphex?

According to official information, regulatory documents advise a general caution regarding the concurrent use of any other medicines, vitamins, or supplements. This is primarily a warning about products that may cause additional drowsiness or contain an active ingredient that is already present in Diphex.


Q: How long does it typically take before a person feels the effects of Diphex?

Official regulatory documents describe the onset of action (the time it takes for effects to begin) for the active ingredients. For an oral solution, the onset is generally reported to be of a short duration, meaning the medicine is expected to begin working relatively quickly after ingestion.


Q: What should I do if I miss a dose of Diphex (general information)?

The patient information provided by regulatory agencies offers general guidance on a missed dose. Official guidance often indicates that if a dose is missed, it may be taken as soon as it is remembered. However, if the next scheduled dose is approaching, the general guidance is to skip the missed dose to prevent exceeding the recommended daily limit.


Q: Does Diphex have a risk of causing dependence or addiction?

Official regulatory documents examine the potential for abuse and dependence for central nervous system (CNS)-active ingredients. The current profile indicates that the medicine's ingredients have a low risk regarding the development of addiction or physical dependence when the solution is used according to the guidelines.


Q: Does Diphex have a drug guide or warning sticker that comes with it?

Regulatory agencies mandate the requirement for accompanying patient materials, such as a Medication Guide or Patient Package Insert (PPI). These documents are provided to ensure all users receive consistent, official information about the medicine's proper use, risks, and safety warnings.


Q: Does Diphex affect fertility or plans to get pregnant?

Official documents contain specific sections detailing information on use in women of childbearing potential, including any available data on reproductive toxicity and fertility. This information often indicates that observed effects on fertility were not reported in animal studies at relevant doses, but clinical human data may be limited.


Q: Is it necessary to have blood tests while taking Diphex?

Regulatory documents specify if routine laboratory monitoring, such as blood tests, is required during treatment. This is relevant to track safety parameters, especially due to the rare documented risk of blood disorders. If required, the official document will explicitly outline the necessary testing schedule.


Q: Does Diphex interact with birth control pills?

According to official regulatory information, hormonal contraceptives, commonly referred to as birth control pills, are not typically cited as a documented pharmacokinetic or pharmacodynamic interaction with Diphex. This information is found in the detailed interaction section of the official label.


Q: What if Diphex doesn't seem to be working after the expected time?

Regulatory labeling for products intended for acute symptoms often defines a specific time frame, such as seven days, during which symptom relief should be expected. Official documents often note that if symptoms persist or worsen beyond the defined period, clinical re-evaluation may be necessary.


Q: Is Diphex considered a controlled substance by government regulators?

The formal classification of a drug as a controlled substance is determined by governmental health and drug enforcement agencies, such as the DEA in the US. According to official records, Diphex is not included on the lists of scheduled controlled substances in the US or in certain other regulatory jurisdictions.


Q: Why does the packaging for Diphex have a specific warning symbol on it (e.g., a triangle)?

In some countries, regulatory agencies mandate the inclusion of specific visual warning symbols, such as a black triangle, on the packaging. These symbols are used to alert patients to specific characteristics of the medicine, such as the potential for drowsiness or the fact that the medicine is being closely monitored following its initial market entry.


Q: Is there a risk of withdrawal symptoms if I stop taking Diphex?

Regulatory documents address the potential for discontinuation phenomena. Because this medicine is officially intended for short-term and intermittent use, the risk of physical withdrawal symptoms following cessation of the drug is generally indicated to be low.


Q: Does Diphex contain lactose or other ingredients that might be a concern for allergies?

Official regulatory documents contain a complete and mandatory list of all excipients, which are the non-active ingredients like preservatives, colorants, or flavorings. This list must be reviewed for any potential known sensitivities, such as an allergy to a specific dye or non-active component.


Q: Can taking Diphex cause sun sensitivity?

Official safety data may note the potential for photosensitivity (sun sensitivity) as an adverse reaction. This describes an exaggerated skin response, similar to a severe sunburn, following sun exposure. Regulatory guidance suggests that protective measures against sun exposure may be warranted while using the medicine.


Q: What are the general rules for taking Diphex with or without food?

Official administration information specifies whether the oral solution should be taken relative to food intake. This is to ensure the food does not affect the medicine's effectiveness or absorption. The regulatory information will clearly indicate whether it should be taken with food, without food, or if the timing relative to meals is not a constraint.


Q: Can Diphex be taken with antacids?

Regulatory drug interaction information addresses the concurrent use of antacids. It may note that certain antacids can affect the absorption of the active ingredients when taken too closely together. Official guidance will specify if a time separation is required between taking Diphex and an antacid dose.


Q: Does Diphex cause weight gain or weight loss?

The official adverse reaction list tracks various systemic effects, including changes in body weight. Weight gain or weight loss are noted in the safety profile if they have been reported with a specific frequency or are considered medically relevant by regulatory bodies.


Q: Is there a link between Diphex and mood changes?

Official safety information for the medicine's central nervous system (CNS)-active ingredients includes descriptions of potential psychological and mood-related effects. These may include nervousness, excitement, or other transient behavioral changes, which are listed in the official safety profile.


Q: Is the generic version of Diphex approved by the FDA (or equivalent regulator)?

Regulatory bodies, such as the FDA, maintain public lists, like the Orange Book, that confirm the approval status of a generic equivalent. These public registers are used to officially confirm whether an approved generic version of the brand-name formulation is currently authorized for use.


Q: Does Diphex interact with herbal teas or natural remedies?

Regulatory documents advise general caution when using Diphex concurrently with herbal teas or natural remedies. This advice is provided because many herbal products have effects on the central nervous system (CNS) and may not be officially tracked for specific drug interactions.


Q: Does Diphex affect my blood sugar levels?

The official safety profile tracks metabolic and endocrine disorders. Official information indicates that the medicine's active ingredients are not typically associated with a documented effect on blood sugar or glucose levels. Any observed impact on blood sugar would be noted in the detailed adverse reaction reports.


Q: What is the meaning of the strength listed on the Diphex packaging?

The strength listed on the packaging is a critical piece of information detailed in the official composition section. It refers to the specific quantity, or mass, of each active ingredient that is present within a defined volume of the oral solution, such as milligrams per milliliter. This ensures the correct concentration is known for proper measurement.

How should Diphex be stored and disposed of?

How to Store and Dispose of Diphex Oral Solution

The storage and disposal of Diphex must strictly follow official regulatory requirements to ensure product stability and prevent unintentional exposure.

Storage Requirements

The oral solution must be kept in its original container and maintained at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The container should be kept tightly closed and stored in a cool and dark place to protect the contents from light and excessive heat. For child safety, the medicine is mandated to be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused medicine should be disposed of using a drug take-back location or mail-back program where available. It is strictly required that the product not be released into the environment or disposed of to the sewer, as all disposal must comply with local and environmental waste legislation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Diphex found in:

A-Z Index: